Carl Zeiss Meditec AG
Carl Zeiss Meditec AG
- Market cap
- $2.63B
- P/E ratio
- 19.10
Your view on CZMWF
Overview
What the company does, where it operates, and who runs it.
About Carl Zeiss Meditec AG
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- CEO
- Andreas Pecher
- Headquarters
- Goschwitzer Strasse 51-52, Jena, DE
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- CEO
- Andreas Pecher
- Headquarters
- Goschwitzer Strasse 51-52, Jena, DE
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery.
The Ophthalmic Devices segment offers products and solutions for the diagnosis and treatment of eye diseases; and systems and consumables for cataract, retinal, and refractive surgeries. It serves practicing ophthalmologists and optometrists, as well as physicians and surgeons in hospitals and outpatient surgery centers.
The Microsurgery segment offers visualization solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, dental and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany.
Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.
Stock Data
Price chart, volume, and trading data.
FRC Fair Value Algorithm
What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.
About this section
Fair value for Carl Zeiss Meditec AG from FRC's valuation model, read against the market price. CZMWF last traded at $30.02, 19.1× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Carl Zeiss Meditec AG. Starting points for Carl Zeiss Meditec AG: P/E 19.1, EPS $1.35, beta 1.44 — an Medical - Instruments & Supplies name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Carl Zeiss Meditec AG. Carl Zeiss Meditec AG does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Carl Zeiss Meditec AG. Trailing twelve-month EPS for Carl Zeiss Meditec AG stands at $1.35. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Carl Zeiss Meditec AG. Carl Zeiss Meditec AG has reported as a listed company since 2012. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| CVALFCovalon Technologies Ltd. | Healthcare | OTC | $35.9M | ||
| CZMWYCarl Zeiss Meditec AG | Healthcare | OTC | $2.7B | ||
| DGENDeltagen Inc. | Healthcare | OTC | $3,859 | ||
| DXRDaxor Corporation | Healthcare | NASDAQ | $43.5M | ||
| ECIAEncision Inc. | Healthcare | OTC | $1.9M | ||
| EKTAFElekta AB (publ) | Healthcare | OTC | $2.2B | ||
| EKTAYElekta AB (publ) | Healthcare | OTC | $2.5B | ||
| EMBCEmbecta Corp. | Healthcare | NASDAQ | $341.1M | ||
| ESLOFEssilorLuxottica S.A. | Healthcare | OTC | $128.6B | ||
| ESLOYEssilorLuxottica S.A. | Healthcare | OTC | $129.8B | ||
| FEMYFemasys Inc. | Healthcare | NASDAQ | $10.7M | ||
| FPH.AXFisher & Paykel Healthcare Corporation Limited | Healthcare | ASX | — | ||
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Carl Zeiss Meditec AG. Coverage tracks Carl Zeiss Meditec AG within Medical - Instruments & Supplies (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Carl Zeiss Meditec AG.